Related Experiment Videos
The scientific rationale for optimizing nutritional support in cancer.
Richard J E Skipworth1, Kenneth C H Fearon
1Clinical and Surgical Sciences (Surgery), School of Clinical Sciences and Community Health, The University of Edinburgh, Royal Infirmary, Edinburgh, UK.
European Journal of Gastroenterology & Hepatology
|April 7, 2007
Summary
Cancer cachexia causes significant weight loss, impacting patient health. Nutritional support is crucial but often ineffective due to complex metabolic changes, necessitating combination therapies.
Area of Science:
- Oncology
- Metabolism
- Nutrition Science
Background:
- Cancer anorexia-cachexia syndrome (CACS) leads to detrimental weight loss in cancer patients.
- This weight loss is linked to increased morbidity and mortality, highlighting the need for effective management.
- Current nutritional support strategies show suboptimal responses due to persistent tumor-induced metabolic alterations.
Purpose of the Study:
- To explore the mechanisms underlying anabolic blockade in cancer cachexia.
- To identify key mediators contributing to weight loss and muscle catabolism.
- To evaluate the limitations of unimodal nutritional interventions and propose future therapeutic strategies.
Main Methods:
- Analysis of alterations in skeletal muscle and hepatic protein metabolism.
- Investigation of neuroendocrine mediators and proinflammatory cytokines.
- Review of tumor-specific cachectic factors influencing metabolism.
Main Results:
- Cancer cachexia involves complex mechanisms including altered protein metabolism and reduced physical activity.
- Proinflammatory cytokines, cachectic factors, and neuroendocrine mediators contribute to muscle catabolism.
- Unimodal nutritional interventions are insufficient due to the multifaceted nature of the syndrome.
Conclusions:
- The complex interplay of mediators in cancer cachexia limits the efficacy of single-approach nutritional support.
- Future research should focus on combination therapies and immunonutrition to improve outcomes.
- Clinical trials are essential to validate novel therapeutic strategies for managing cancer cachexia.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...